Discover 1,431 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,431
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
for
Atrial Fibrillation (AF)
Location: Moncton, Rimouski, Boston MA, Quebec, Sherbrooke,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07175428
Phase 2, Recruiting
Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer
for
Non Small Cell Lung Cancer, Metastatic Lung Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT06622174
Phase 1, Recruiting
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
for
Alopecia Areata
Location: Boston MA, Quebec, Montreal, Plymouth Meeting PA,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07733765
Phase 3, Recruiting
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
for
Higher-risk Myelodysplastic Syndrome
Location: The Bronx NY, New York NY, Hackensack NJ, Montreal,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06641414
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Reducing Systemic Inflammation in People on Antiretroviral Therapy
for
Human Immunodeficiency Virus (HIV), Cardiovascular Risk Factor
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT07030920
Phase 2, Recruiting
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Danvers MA, Newton MA, Boston MA, Providence RI,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase 3, Recruiting
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
for
Non-Segmental Vitiligo (NSV), Alopecia Areata,
Location: Fredericton, Pointe-Claire, Markham, Richmond Hill,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07136467
Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia
for
Sickle Cell Disease (SCD)
Location: Montreal
Sponsor: Yves Pastore
Sex: All
Age: 0 - 18
Code: NCT06761560
Phase 2, Phase 3, Recruiting
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
for
Castration-Resistant Prostatic Cancer, Metastasis
Location: Sherbrooke, New York NY, Montreal, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06863272
Phase 1, Phase 2, Recruiting
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
for
Hidradenitis Suppurativa
Location: New York NY, Montreal, Quebec, Miami FL, Charleston SC,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07665437
Phase 3, Recruiting
Lesion Size Measurement During Gastrointestinal Endoscopies
for
Polyp of Colon, Crohn Disease
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT07770425
Recruiting
Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for
Acute Myeloid Leukemia (AML)
Location: Worcester MA, Hartford CT, New Haven CT, New York NY,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07007312
Phase 3, Recruiting
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
for
Small Cell Lung Carcinoma,
Location: Boston MA, Montreal, Royal Oak MI, Iowa City IA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07006727
Phase 1, Recruiting
Alleviant ALLAY-HFrEF Study
for
Heart Failure
Location: Boston MA, Quebec, New York NY, Montreal, Englewood NJ,
Sponsor: Alleviant Medical, Inc.
Sex: All
Age: 18+
Code: NCT06812533
Recruiting
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
for
Non-alcoholic Fatty Liver Disease
Location: Quebec, New York NY, Norfolk VA, Morehead City NC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07221227
Phase 3, Recruiting
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
for
Radiographic Axial Spondyloarthritis
Location: Quebec, Trois-Rivieres, Philadelphia PA, Baltimore MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07133633
Phase 2, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Hartford CT, Sherbrooke, New York NY, Montreal,